D.E. Shaw & Co’s Adaptimmune Therapeutics ADAP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-26,579
| Closed | -$40K | – | 2617 |
|
|
2019
Q3 | $40K | Sell |
26,579
-51,411
| -66% | -$77.4K | ﹤0.01% | 2490 |
|
|
2019
Q2 | $314K | Sell |
77,990
-216,583
| -74% | -$872K | ﹤0.01% | 2293 |
|
|
2019
Q1 | $1.27M | Buy |
294,573
+80,412
| +38% | +$346K | ﹤0.01% | 1766 |
|
|
2018
Q4 | $1.23M | Buy |
+214,161
| New | +$1.23M | ﹤0.01% | 1766 |
|
|
2018
Q2 | – | Sell |
-31,367
| Closed | -$352K | – | 2545 |
|
|
2018
Q1 | $352K | Sell |
31,367
-50,253
| -62% | -$564K | ﹤0.01% | 2190 |
|
|
2017
Q4 | $545K | Sell |
81,620
-119
| -0.1% | -$795 | ﹤0.01% | 2058 |
|
|
2017
Q3 | $669K | Buy |
81,739
+46,243
| +130% | +$378K | ﹤0.01% | 1958 |
|
|
2017
Q2 | $159K | Sell |
35,496
-56,371
| -61% | -$253K | ﹤0.01% | 2287 |
|
|
2017
Q1 | $506K | Sell |
91,867
-8,656
| -9% | -$47.7K | ﹤0.01% | 1984 |
|
|
2016
Q4 | $407K | Buy |
100,523
+18,216
| +22% | +$73.8K | ﹤0.01% | 2112 |
|
|
2016
Q3 | $580K | Buy |
82,307
+71,177
| +640% | +$502K | ﹤0.01% | 1943 |
|
|
2016
Q2 | $91K | Sell |
11,130
-702
| -6% | -$5.74K | ﹤0.01% | 2453 |
|
|
2016
Q1 | $96K | Buy |
+11,832
| New | +$96K | ﹤0.01% | 2483 |
|
|
2015
Q3 | – | Sell |
-15,232
| Closed | -$279K | – | 2527 |
|
|
2015
Q2 | $279K | Buy |
+15,232
| New | +$279K | ﹤0.01% | 2359 |
|